EV/EBITDA
14.25
-0.02-0.14%
Fri, 29 Nov 2024 20:40:36 GMT
Summary:
Amneal Pharmaceuticals EV/EBITDA is currently 14.25, with a fall of -0.02 (-0.14%) during the most recent trading day. Over the past year, it has increased by +5.56 (+63.98%). AMRX EV/EBITDA is now -88.58% below its all-time high of 124.82.AMRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -0.1% |
| 1 m1 month | -1.3% |
| 3 m3 months | -7.0% |
| 6 m6 months | +3.3% |
| ytdytd | +26.0% |
| 1 y1 year | +64.0% |
| 5 y5 years | -9.5% |
AMRX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 14.91 | -4.4% | 14.10 | +1.1% |
| 3 m | 3 months | 15.40 | -7.5% | 14.10 | +1.1% |
| 6 m | 6 months | 15.40 | -7.5% | 13.21 | +7.9% |
| 1 y | 1 year | 15.40 | -7.5% | 8.65 | +64.7% |
| 3 y | 3 years | 29.13 | -51.1% | 6.97 | +104.5% |
| 5 y | 5 years | 29.13 | -51.1% | 6.97 | +104.5% |
| alltime | all time | 124.82 | -88.6% | -90.04 | +115.8% |
Amneal Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 14.25(+26.0%) |
| 2023 | 11.31(-45.5%) |
| 2022 | 20.74(+148.7%) |
| Date | Value |
|---|---|
| 2021 | 8.34(-12.1%) |
| 2020 | 9.49(-55.7%) |
| 2019 | 21.44(-60.1%) |
| 2018 | 53.69 |
FAQ
- What is Amneal Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Amneal Pharmaceuticals?
- What is AMRX EV/EBITDA year-to-date change?
- What is Amneal Pharmaceuticals EV/EBITDA year-on-year change?
What is Amneal Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of AMRX is 14.25
What is the all time high EV/EBITDA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high EV/EBITDA is 124.82
What is AMRX EV/EBITDA year-to-date change?
Amneal Pharmaceuticals EV/EBITDA has changed by +2.94 (+25.99%) since the beginning of the year
What is Amneal Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, AMRX EV/EBITDA has changed by +5.56 (+63.98%)